AAAAAA
Results:
1-7
|
Results: 7
Authors:
NAHATA MC
WELTY TE
Citation: Mc. Nahata et Te. Welty, TROUBLING ISSUES WITH RESEARCH PUBLICATIONS, The Annals of pharmacotherapy, 32(1), 1998, pp. 126-128
Authors:
WELTY TE
PRIVITERA M
SHUKLA R
Citation: Te. Welty et al., INCREASED SEIZURE FREQUENCY ASSOCIATED WITH FELBAMATE WITHDRAWAL IN ADULTS, Archives of neurology, 55(5), 1998, pp. 641-645
Authors:
GIDAL BE
WELTY TE
Citation: Be. Gidal et Te. Welty, LETTERS TO THE EDITOR, Epilepsia, 38(2), 1997, pp. 260-260
Authors:
PRIVITERA M
WELTY TE
Citation: M. Privitera et Te. Welty, ACUTE PHENYTOIN TOXICITY FOLLOWED BY SEIZURE BREAKTHROUGH FROM A TICLOPIDINE-PHENYTOIN INTERACTION, Archives of neurology, 53(11), 1996, pp. 1191-1192
Authors:
WELTY TE
PRIVITERA M
Citation: Te. Welty et M. Privitera, INCREASED SEIZURE FREQUENCY DURING AND IMMEDIATELY FOLLOWING FELBAMATE WITHDRAWAL, Epilepsia, 36, 1995, pp. 328-328
Authors:
WELTY TE
Citation: Te. Welty, PRIOR CALCIUM-CHANNEL ANTAGONIST USE AND ISCHEMIC STROKE OUTCOMES, The Annals of pharmacotherapy, 28(5), 1994, pp. 671-671
Authors:
WELTY TE
COPA AK
Citation: Te. Welty et Ak. Copa, IMPACT OF VANCOMYCIN THERAPEUTIC DRUG-MONITORING ON PATIENT-CARE, The Annals of pharmacotherapy, 28(12), 1994, pp. 1335-1339
Risultati:
1-7
|